Article
Hepatic lipogenesis marked by GCKR-modulated triglycerides increases serum FGF21 in children/teens with obesity.
Diabetes, obesity & metabolism - 1 Feb 2025
Maffeis Claudio, Morandi Anita, Zusi Chiara, Olivieri Francesca, Fornari Elena, Cavarzere Paolo, Piona Claudia, Corradi Massimiliano, Emiliani Federica, Da Ros Alessandro, Berni Canani Roberto, Mantovani Alessandro, Targher Giovanni
Abstract excerpt
AIMS: Fibroblast growth factor 21 (FGF21) decreases hepatic lipogenesis in animal models, and FGF21 analogues decrease serum triglycerides (TG) in adults in phase-2 trials. On the other hand, serum FGF21 is associated with higher TG in observational studies of people with obesity, raising a sort of paradox. We tested the hypothesis that FGF21 is induced by TG in youth with obesity, as a compensatory mechanism....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
